Structural basis of the GM2 gangliosidosis B variant

[1]  Timm Maier,et al.  The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease. , 2003, Journal of molecular biology.

[2]  M. James,et al.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. , 2003, Journal of molecular biology.

[3]  H. Doi,et al.  Molecular and structural studies of the GM2 gangliosidosis 0 variant , 2002, Journal of Human Genetics.

[4]  S. Withers,et al.  Crystallographic Evidence for Substrate-assisted Catalysis in a Bacterial β-Hexosaminidase* , 2001, The Journal of Biological Chemistry.

[5]  Zbigniew Dauter,et al.  Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay–Sachs disease , 1996, Nature Structural Biology.

[6]  G. Isshiki,et al.  Molecular genetics of Tay-Sachs disease in Japan , 1994, Journal of Inherited Metabolic Disease.

[7]  M. Natowicz,et al.  A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. , 1992, Human molecular genetics.

[8]  J. Clarke,et al.  Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease. , 1991, American journal of human genetics.

[9]  M. Ribeiro,et al.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal. , 1991, American journal of human genetics.

[10]  J. Chelly,et al.  Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. , 1991, Genomics.

[11]  E. Nanba,et al.  Expression of the beta-hexosaminidase alpha subunit gene with the four-base insertion of infantile Jewish Tay-Sachs disease. , 1991, The Journal of biological chemistry.

[12]  B. Paw,et al.  A third mutation at the CpG dinucleotide of codon 504 and a silent mutation at codon 506 of the HEX A gene. , 1991, American journal of human genetics.

[13]  R. Boustany,et al.  Genetic cause of a juvenile form of tay‐sachs disease in a lebanese child , 1991, Annals of neurology.

[14]  B. Paw,et al.  Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase. , 1990, The Journal of biological chemistry.

[15]  A. Brown,et al.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. , 1990, American journal of human genetics.

[16]  D. Mahuran,et al.  Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity. , 1989, The Journal of biological chemistry.

[17]  R. Myerowitz,et al.  The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. , 1988, The Journal of biological chemistry.

[18]  B. Paw,et al.  Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation. , 1988, The Journal of biological chemistry.

[19]  K. Ohno,et al.  Mutation in GM2‐Gangliosidosis B1 Variant , 1988, Journal of neurochemistry.

[20]  T L Blundell,et al.  Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. , 1987, Protein engineering.

[21]  T. A. Jones,et al.  Using known substructures in protein model building and crystallography. , 1986, The EMBO journal.

[22]  K. Sandhoff,et al.  Variant of GM2‐gangliosidosis with hexosaminidase A having a severely changed substrate specificity. , 1983, The EMBO journal.

[23]  W. Kabsch.  A discussion of the solution for the best rotation to relate two sets of vectors , 1978 .

[24]  W. Kabsch.  A solution for the best rotation to relate two sets of vectors , 1976 .

[25]  A. Tanaka,et al.  A New Point Mutation in the 0-Hexosaminidase a Subunit Gene Responsible for Infantile Tay-Sachs Disease in a Non-Jewish Caucasian Patient (a Kpn Mutant) , 2006 .

[26]  G. Isshiki,et al.  Novel mutations, including the second most common in Japan, in the beta-hexosaminidase alpha subunit gene, and a simple screening of Japanese patients with Tay-Sachs disease. , 1999, Journal of human genetics.

[27]  A. Kahn,et al.  Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients. , 1993, Human molecular genetics.

[28]  G. Isshiki,et al.  The major mutation among Japanese patients with infantile Tay-Sachs disease: a G-to-T transversion at the acceptor site of intron 5 of the beta-hexosaminidase alpha gene. , 1993, Biochemical and biophysical research communications.

[29]  G. Thomas,et al.  Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals. , 1992, American journal of human genetics.

[30]  S. Wodak,et al.  Modelling the polypeptide backbone with 'spare parts' from known protein structures. , 1989, Protein engineering.

[31]  K. Ohno,et al.  GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. , 1988, Biochemical and biophysical research communications.

[32]  K. Suzuki.  Enzymatic diagnosis of sphingolipidoses. , 1987, Methods in enzymology.

[33]  H. Berman,et al.  Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank , 2022 .